Dyadic International, Inc. (NASDAQ: DYAI)

Dyadic International, Inc. (NASDAQ: DYAI) –. We are a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health.

With a passion to enable our partners and collaborators to develop effective preventative and therapeutic treatments in both developed and emerging countries, Dyadic is building an active pipeline by advancing its proprietary filamentous fungal based microbial platform technologies, including C1 and Dapibus™.